• Latest Posts

CytoMed Therapeutics receives US patent for CAR-Gamma Delta T-cell technology

LIfT produces neutrophil-based cell therapy from iPSCs

AstraZeneca non-small cell lung cancer drug meets primary endpoint

Innovent and IASO Bio obtain approval for CAR-T multiple myeloma treatment 

New drug helps prostate cancer patients

Exeliom Biosciences closes €24M financing for lead candidate 

ADVERTISEMENT

FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

European Coalition for Access to Comprehensive Genomic Profiling launched

Ovarian cancer study finds key genes for potential treatments

Nanobody company Attovia Therapeutics launches with $60M  

FDA clears T-Cell receptor natural killer cell therapy for sarcoma

ADVERTISEMENT